| Literature DB >> 29518084 |
Kouki Tomari1, Takao Toyokawa2, Takuto Takahashi3, Tetsuya Kakita4, Sho Okano4, Hisako Kyan4, Naoya Tonegawa1, Teppei Okawa1, Takashi Matsuoka1, Tsutomu Matsumora1.
Abstract
Leptospirosis is considered underdiagnosed because of its nonspecific presentation and lack of proper understanding of its epidemiology. Early diagnosis and treatment are crucial. However, few data are available on confirmed leptospirosis cases in children in industrialized countries. We therefore aimed to describe epidemiologic and clinical characteristics of laboratory-confirmed childhood leptospirosis in Okinawa, Japan. We reviewed the national surveillance data of pediatric leptospirosis in Okinawa, Japan from January 2003 through December 2015. The database included all of laboratory-confirmed leptospirosis diagnosed at the only central laboratory for leptospirosis in the region. There were 44 children (0-20 years of age) with laboratory-confirmed leptospirosis. Of these, 90% were male, 91% were 10-20 years of age, and 96% of cases occurred in August and September. The number of laboratory-confirmed patients ranged from 0 to 11 per year (mean: 3.3 per year), and the estimated annual rate was 1.0 per 100,000 pediatric populations. In all cases, the presumed infection route was recreational exposure to river water. Commonly observed manifestations include fever (95%), myalgia (52%), and conjunctival suffusion (52%). Childhood leptospirosis in Okinawa, Japan occurred predominantly in teenage boys after freshwater exposure in summer, and most patients had characteristic conjunctival suffusion. Cohort studies would be helpful to better understand more detailed clinical manifestations in association with prognosis.Entities:
Mesh:
Year: 2018 PMID: 29518084 PMCID: PMC5860792 DOI: 10.1371/journal.pntd.0006294
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Patient characteristics, no. (%).
| Participants | |
|---|---|
| n = 44 | |
| Male sex | 40 (91) |
| Age in years, median (range) | 14 (5–20) |
| 0–10 years old | 4 (9) |
| 11–20 years old | 40 (91) |
| Exposure | |
| Freshwater | 41 (93) |
| Unknown | 3 (7) |
| Season of onset | |
| August | 11 (25) |
| September | 31 (70) |
| October | 1 (2) |
| November | 1 (2) |
Fig 1Annual number of cases.
Adult leptospirosis cases reported in Okinawa [5] are shown for comparison.
Patient characteristics (n = 44), no. (%).
| Clinical features | Serogroups of Leptospira* | ||
|---|---|---|---|
| Fever | 42 (96) | Hebdomadis | 28 (64) |
| Myalgia | 23 (52) | Autumnalis | 8 (18) |
| Conjunctival suffusion | 23 (52) | Pyrogenes | 3 (7) |
| Gastroenteritis-like symptoms | 15 (34) | Grippotyphosa | 2 (5) |
| Liver dysfunction | 12 (27) | Australis | 1 (2) |
| Renal dysfunction | 11 (25) | Cross-reaction | 1 (2) |
| Arthralgia | 10 (23) | Untested | 1 (2) |
| Jaundice | 6 (14) | ||
| Headache | 6 (14) | ||
| Meningitis | 4 (9) | ||
| Lymphadenopathy | 2 (5) | ||
| Altered mental status | 2 (5) | ||
| Rash | 1 (2) | ||
Comparison between this study and Tsuha's study, no. (%).
| This study | Tsuha’s study | |
|---|---|---|
| Clinical features | ||
| Fever | 42 (96) | 90 (90) |
| Myalgia | 23 (52) | 48 (48) |
| Conjunctival suffusion | 23 (52) | 66 (66) |
| Liver dysfunction | 12 (27) | 15 (15) |
| Renal dysfunction | 11 (25) | 11 (11) |
| Arthralgia | 10 (23) | 25 (25) |
| Jaundice | 6 (14) | 13 (13) |
| Headache | 6 (14) | 76 (76) |
| Meningitis | 4 (9) | 2 (2) |
| Lymphadenopathy | 2 (5) | 5 (5) |
| Altered mental status | 2 (5) | ND |
| Rash | 1 (2) | 0 (0) |
| Cough | 0 (0) | 16 (16) |
| Hemorrhage | 0 (0) | 5 (5) |
| Serogroups of Leptospira | ||
| Hebdomadis | 28 (64) | 25 (34) |
| Autumnalis | 8 (18) | 6 (8) |
| Pyrogenes | 3 (7) | 14 (19) |
| Grippotyphosa | 2 (5) | 1 (1) |
| Australis | 1 (2) | 0 (0) |
| Javanica | 0 (0) | 5 (7) |
| Canicola | 0 (0) | 3 (4) |
| Not determined | 2 (5) | 20 (27) |
*This study used Microscopic Agglutination Test.
†Tsuha’s study identified serovars using Korthof media and 74 cases were diagnosed.
**One case: cross reaction, the other case: not tested.